Tuesday 20 March 2018

UDG proposes €407.5m sale of Irish distribution businesses, CEO FitzGerald to retire

UDG is a leading pharmaceutical distributor
UDG is a leading pharmaceutical distributor
Gavin McLoughlin

Gavin McLoughlin

Irish healthcare company UDG is proposing to sell its Irish pharmaceutical distribution businesses and its UK-based travel healthcare business to for €407.5m.

The company buying the businesses is McKesson, a pharmaceutical wholesaler and retail pharmacy group that is one of the largest companies on the Fortune 500.

UDG said the deal "will transform UDG Healthcare into a more focused international healthcare services business."

"This is consistent with UDG Healthcare’s strategy over the last few years to focus on its higher-growth, higher-margin businesses," it added.

The deal is conditional on shareholder and regulatory approval.

UDG also said its CEO Liam FitzGerald plans to retire on March 31 2016, remaining with as a consultant and Director until September 30 2016.

The company's COO Brendan McAtamney will be his successor.

Online Editors

Business Newsletter

Read the leading stories from the world of Business.

Also in Business